SynthesisAnnals of hematology2024

Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysis.

Shuo Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.